| Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research JE Signorovitch, V Sikirica, MH Erder, J Xie, M Lu, PS Hodgkins, KA Betts, ... Value in Health 15 (6), 940-947, 2012 | 401 | 2012 |
| Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis AW Armstrong, L Puig, A Joshi, M Skup, D Williams, J Li, KA Betts, ... JAMA dermatology 156 (3), 258-269, 2020 | 224 | 2020 |
| Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended 4‐year follow‐up and analysis of relative progression‐free survival from the … MA Dimopoulos, S Lonial, KA Betts, C Chen, ML Zichlin, A Brun, ... Cancer 124 (20), 4032-4043, 2018 | 162 | 2018 |
| Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer D Waterhouse, J Lam, KA Betts, L Yin, S Gao, Y Yuan, J Hartman, S Rao, ... Lung Cancer 156, 41-49, 2021 | 93 | 2021 |
| The prevalence of hyperkalemia in the United States KA Betts, JM Woolley, F Mu, E McDonald, W Tang, EQ Wu Current medical research and opinion 34 (6), 971-978, 2018 | 92 | 2018 |
| Comparative efficacy of biological treatments for moderate‐to‐severe psoriasis: a network meta‐analysis adjusting for cross‐trial differences in reference arm response JE Signorovitch, KA Betts, YS Yan, C LeReun, M Sundaram, EQ Wu, ... British journal of dermatology 172 (2), 504-512, 2015 | 84 | 2015 |
| Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials JE Signorovitch, EQ Wu, KA Betts, K Parikh, E Kantor, A Guo, VK Bollu, ... Current medical research and opinion 27 (6), 1263-1271, 2011 | 78 | 2011 |
| Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the VISUAL-1 and VISUAL-2 trials J Sheppard, A Joshi, KA Betts, S Hudgens, S Tari, N Chen, M Skup, ... JAMA ophthalmology 135 (6), 511-518, 2017 | 72 | 2017 |
| ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work … D van der Heijde, A Joshi, AL Pangan, N Chen, K Betts, M Mittal, Y Bao Rheumatology 55 (1), 80-88, 2016 | 72 | 2016 |
| Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter MAA El-Din, KS Hughes, DM Finkelstein, KA Betts, TI Yock, NJ Tarbell, ... International Journal of Radiation Oncology* Biology* Physics 73 (1), 69-74, 2009 | 67 | 2009 |
| The cost of hyperkalemia in the United States KA Betts, JM Woolley, F Mu, C Xiang, W Tang, EQ Wu Kidney international reports 3 (2), 385-393, 2018 | 61 | 2018 |
| Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe plaque psoriasis: a network meta-analysis AW Armstrong, AM Soliman, KA Betts, Y Wang, Y Gao, L Puig, M Augustin Dermatology and therapy 11, 885-905, 2021 | 54 | 2021 |
| Comparative efficacy of JAK inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis J Pope, R Sawant, N Tundia, EX Du, CZ Qi, Y Song, P Tang, KA Betts Advances in therapy 37, 2356-2372, 2020 | 50 | 2020 |
| Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis JF Donohue, KA Betts, EX Du, P Altman, P Goyal, DL Keininger, ... International journal of chronic obstructive pulmonary disease, 367-381, 2017 | 45 | 2017 |
| Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data NH Shear, KA Betts, AM Soliman, A Joshi, Y Wang, J Zhao, P Gisondi, ... Journal of the American Academy of Dermatology 85 (3), 572-581, 2021 | 43 | 2021 |
| Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis AW Armstrong, KA Betts, JE Signorovitch, M Sundaram, J Li, AX Ganguli, ... Current medical research and opinion 34 (7), 1325-1333, 2018 | 38 | 2018 |
| Corticosteroid-related adverse events systematically increase with corticosteroid dose in noninfectious intermediate, posterior, or panuveitis: post hoc analyses from the … EB Suhler, JE Thorne, M Mittal, KA Betts, S Tari, A Camez, Y Bao, A Joshi Ophthalmology 124 (12), 1799-1807, 2017 | 36 | 2017 |
| Real-world costs of ischemic stroke by discharge status F Mu, D Hurley, KA Betts, AJ Messali, M Paschoalin, C Kelley, EQ Wu Current Medical Research and Opinion 33 (2), 371-378, 2017 | 34 | 2017 |
| Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics … V Sikirica, SR Pliszka, KA Betts, P Hodgkins, T Samuelson, J Xie, ... Journal of Managed Care Pharmacy 18 (9), 676-689, 2012 | 34 | 2012 |
| Prevalence and economic burden of hyperkalemia in the United States Medicare population F Mu, KA Betts, JM Woolley, A Dua, Y Wang, J Zhong, EQ Wu Current medical research and opinion 36 (8), 1333-1341, 2020 | 33 | 2020 |
Ella Xiaoyan DuManager at Analysis Group, Inc.Verified email at analysisgroup.com
